Loading clinical trials...
Loading clinical trials...
Randomised, Cross Over Pilot Study Comparing Removal of beta2-Microglobulin by Standard Haemodialysis to Haemodialysis With a Novel Dialysis Membrane (P2SH) in Chronic Dialysis Patients
Conditions
Interventions
Larger pore haemodialysis membrane
Standard haemodialysis membrane
Locations
1
Australia
Austin Health
Melbourne, Victoria, Australia
Start Date
October 1, 2008
Primary Completion Date
December 1, 2008
Completion Date
December 1, 2008
Last Updated
July 7, 2009
NCT05755503
NCT05161078
NCT07312929
NCT05729113
NCT05711810
NCT04944433
Lead Sponsor
Austin Health
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions